Jeil Pharm and Cheil Jedang to jointly develop anti-diabetic drug

Published: 2002-03-11 06:57:00

Updated: 2002-03-11 06:57:00

Jeil Pharm says that in parallel with the government's landmark long-term plan to actively promote the bioengineering technology industry on a continual basis, it will initiate a large-scale R&D new drug project to develop new candidates of antidiabetic agent through the joint collaboration betwe...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK